Gada Al-Ani

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu et al. · Cancer Cell · 2019 · 270 citations

Pdgfra Variants, Oncogenic Agent, Medicine +9

The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors

Allison S. Harney, George S. Karagiannis, Jeanine Pignatelli et al. · Molecular Cancer Therapeutics · 2017 · 162 citations · Full text

PIASy Mediates SUMO-2/3 Conjugation of Poly(ADP-ribose) Polymerase 1 (PARP1) on Mitotic Chromosomes

Hyunju Ryu, Gada Al-Ani, Katelyn Deckert et al. · Journal of Biological Chemistry · 2010 · 60 citations · Full text

Genetics, Sumoylation Assays, Molecular Biology +16

Quantitative Determination of Binding of ISWI to Nucleosomes and DNA Shows Allosteric Regulation of DNA Binding by Nucleotides

Gada Al-Ani, Koan Briggs, Shuja Shafi Malik et al. · Biochemistry · 2014 · 13 citations · Full text

Chromatin Remodeler Iswi, Quantitative Determination, Molecular Biology +24

Leishmania dihydroxyacetonephosphate acyltransferase LmDAT is important for ether lipid biosynthesis but not for the integrity of detergent resistant membranes

Rachel Zufferey, Gada Al-Ani, Kara Dunlap · Molecular and Biochemical Parasitology · 2009 · 11 citations · Full text

Proteinlipid Interaction, Biosynthesis, Biochemistry +7